BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1206104)

  • 1. Normalization of fasting hyperglucagonemia and excessive glucagon responses to intravenous arginine in human diabetes mellitus by prolonged infusion of insulin.
    Gerich JE; Tsalikian E; Lorenzi M; Schneider V; Bohannon NV; Gustafson G; Karam JH
    J Clin Endocrinol Metab; 1975 Dec; 41(06):1178-80. PubMed ID: 1206104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the suppressive effects of elevated plasma glucose and free fatty acid levels on glucagon secretion in normal and insulin-dependent diabetic subjects. Evidence for selective alpha-cell insensitivity to glucose in diabetes mellitus.
    Gerich JE; Langlois M; Noacco C; Lorenzi M; Karam JH; Korsham PH
    J Clin Invest; 1976 Aug; 58(2):320-5. PubMed ID: 783198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of intermittent endogenous hyperglucagonemia on glucose homeostasis in normal and diabetic man.
    Rizza R; Verdonk C; Miles J; Service FJ; Gerich J
    J Clin Invest; 1979 Jun; 63(6):1119-23. PubMed ID: 447838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perfect normalization of excessive glucagon responses to intravenous arginine in human diabetes mellitus with the artificial beta-cell.
    Kawamori R; Shichiri M; Kikuchi M; Yamasaki Y; Abe H
    Diabetes; 1980 Sep; 29(9):762-5. PubMed ID: 7002690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of insulin-glucose infusions on plasma glucagon levels in fasting diabetics and nondiabetics.
    Raskin P; Fujita Y; Unger RH
    J Clin Invest; 1975 Nov; 56(5):1132-8. PubMed ID: 1184740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alteration of plasma glucagon response to arginine after treatment in patients with diabetes mellitus, cushing's syndrome and hypothyroidism.
    Seino Y; Goto Y; Kurahachi H; Sakurai H; Ikeda M
    Horm Metab Res; 1977 Jan; 9(1):28-32. PubMed ID: 844789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies of pancreatic alpha cell function in normal and diabetic subjects.
    Unger RH; Aguilar-Parada E; Müller WA; Eisentraut AM
    J Clin Invest; 1970 Apr; 49(4):837-48. PubMed ID: 4986215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of metformin on arginine-induced glucagon secretion in human diabetes.
    Carpentier J; Luyckx AS; Lefebvre PJ
    Diabete Metab; 1975 Mar; 1():23-8. PubMed ID: 1234063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum insulin, pancreatic glucagon and growth hormone levels in response to intravenous infusion of L-arginine in patients with recently detected juvenile diabetes.
    Lawecki J; Symonides-Lawecka A; Rogala H
    Pol Med Sci Hist Bull (1973); 1976; 15(2):177-82. PubMed ID: 959042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Normal glucagon response to arginine infusion in "prediabetic" Pima Indians.
    Aronoff SL; Bennett PH; Rushforth NB; Miller M; Unger RH
    J Clin Endocrinol Metab; 1976 Aug; 43(2):279-86. PubMed ID: 950363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma glucagon and insulin concentrations in acromegaly.
    Trimble ER; Atkinson AB; Buchanan KD; Hadden DR
    J Clin Endocrinol Metab; 1980 Sep; 51(3):626-31. PubMed ID: 6997331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Xylitol: stimulation of insulin and inhibition of glucagon responses to arginine in man.
    Seino Y; Taminato T; Inoue Y; Goto Y; Ikeda M
    J Clin Endocrinol Metab; 1976 Apr; 42(4):736-43. PubMed ID: 1262446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal response of pancreatic glucagon to glycemic changes in diabetes mellitus.
    Ohneda A; Watanabe K; Horigome K; Sakai T; Kai Y; Oikawa S
    J Clin Endocrinol Metab; 1978 Mar; 46(3):504-10. PubMed ID: 752036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arginine-stimulated hyperglucagonemia in diabetic Pima Indians.
    Aronoff SL; Bennett PH; Rushforth NB; Miller M; Unger RH
    Diabetes; 1976 May; 25(5):404-7. PubMed ID: 1269839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of acute insulin withdrawal and administration on plasma glucagon responses to intravenous arginine in insulin-dependent diabetic subjects.
    Gerich JE; Lorenzi M; Tsalikian E; Bohannon NV; Schneider V; Karam JH; Forsham PH
    Diabetes; 1976 Oct; 25(10):955-60. PubMed ID: 976604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possible role of alpha-cell insulin resistance in exaggerated glucagon responses to arginine in type 2 diabetes.
    Tsuchiyama N; Takamura T; Ando H; Sakurai M; Shimizu A; Kato K; Kurita S; Kaneko S
    Diabetes Care; 2007 Oct; 30(10):2583-7. PubMed ID: 17644622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucagon response to arginine after treatment of diabetes mellitus.
    Ohneda A; Ishii S; Horigome K; Yamagata S
    Diabetes; 1975 Sep; 24(9):811-9. PubMed ID: 1158041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exaggerated glucagon secretion in diabetic and non-diabetic subjects with surgical porto-caval anastomosis.
    Fallucca F; Ziparo V; Giangrande L; Menzinger G; Stipa S
    Horm Metab Res; 1981 Oct; 13(10):545-7. PubMed ID: 7298009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperglucagonemia and blood glucose regulation in normal, obese and diabetic subjects.
    Sherwin RS; Fisher M; Hendler R; Felig P
    N Engl J Med; 1976 Feb; 294(9):455-61. PubMed ID: 1246330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Demonstration of gastric glucagon hypersecretion in insulin-deprived alloxan-diabetic dogs.
    Blazquez E; Muñoz-Barragan L; Patton GS; Dobbs RE; Unger RH
    J Lab Clin Med; 1977 May; 89(5):971-7. PubMed ID: 870572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.